T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Teva Pharmaceuticals
TEVA
$21.4B
| $6.24M | ﹤0.01% |
405,692
-1,643,696
| -80% | -$25.3M |
|
1202
EnerSys
ENS
$4.04B
| $6.23M | ﹤0.01% |
68,065
+12,044
| +21% | +$1.1M |
|
1203
Albertsons Companies
ACI
$10.3B
| $6.15M | ﹤0.01% |
279,777
+33,420
| +14% | +$735K |
|
1204
Allogene Therapeutics
ALLO
$262M
| $6.14M | ﹤0.01% |
4,206,004
-279,568
| -6% | -$408K |
|
1205
Kosmos Energy
KOS
$870M
| $6.13M | ﹤0.01% |
2,688,836
-3,859,941
| -59% | -$8.8M |
|
1206
GFL Environmental
GFL
$16.9B
| $6.09M | ﹤0.01% |
126,019
-5,081
| -4% | -$245K |
|
1207
Constellium
CSTM
$2.09B
| $6.07M | ﹤0.01% |
601,425
-652,101
| -52% | -$6.58M |
|
1208
Hawkins
HWKN
$3.62B
| $6.06M | ﹤0.01% |
57,187
+646
| +1% | +$68.4K |
|
1209
Sony
SONY
$172B
| $6.02M | ﹤0.01% |
+237,200
| New | +$6.02M |
|
1210
SharkNinja
SN
$15.9B
| $6.01M | ﹤0.01% |
72,016
+535
| +0.7% | +$44.6K |
|
1211
Cullen/Frost Bankers
CFR
$8.08B
| $5.93M | ﹤0.01% |
47,311
+3,251
| +7% | +$407K |
|
1212
New York Times
NYT
$9.49B
| $5.91M | ﹤0.01% |
119,180
+7,566
| +7% | +$375K |
|
1213
Novartis
NVS
$238B
| $5.87M | ﹤0.01% |
52,648
-21,240
| -29% | -$2.37M |
|
1214
Houlihan Lokey
HLI
$14.3B
| $5.81M | ﹤0.01% |
35,974
+2,166
| +6% | +$350K |
|
1215
Noble Corp
NE
$5.02B
| $5.79M | ﹤0.01% |
244,037
-2,176,207
| -90% | -$51.6M |
|
1216
Thryv Holdings
THRY
$533M
| $5.67M | ﹤0.01% |
442,842
+1,996
| +0.5% | +$25.6K |
|
1217
Taylor Morrison
TMHC
$6.75B
| $5.66M | ﹤0.01% |
94,209
+8,071
| +9% | +$485K |
|
1218
Regal Rexnord
RRX
$9.38B
| $5.64M | ﹤0.01% |
49,552
+3,075
| +7% | +$350K |
|
1219
Lithia Motors
LAD
$8.51B
| $5.6M | ﹤0.01% |
19,075
+1,730
| +10% | +$508K |
|
1220
Donaldson
DCI
$9.42B
| $5.56M | ﹤0.01% |
82,944
+12,872
| +18% | +$863K |
|
1221
Birkenstock
BIRK
$8.4B
| $5.55M | ﹤0.01% |
121,063
-5,533
| -4% | -$254K |
|
1222
Tetra Tech
TTEK
$9.58B
| $5.55M | ﹤0.01% |
189,655
+14,767
| +8% | +$432K |
|
1223
Comerica
CMA
$8.8B
| $5.55M | ﹤0.01% |
93,914
+7,867
| +9% | +$465K |
|
|
BERY
1224
DELISTED
Berry Global Group, Inc.
BERY
| $5.49M | ﹤0.01% |
78,639
-8,046
| -9% | -$562K |
|
1225
AGNC Investment
AGNC
$10.7B
| $5.48M | ﹤0.01% |
572,084
+86,074
| +18% | +$825K |
|